Trial intelligence / Profile preview

Intraperitoneal versus intravenous dexamethasone after gynecologic laparoscopic surgery

IRCT20160523028008N18Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Nov 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexamethasone (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Postoperative nausea severity, Postoperative vomiting severity and 1 more. Started Nov 2021; status: completed.

02

Drugs

dexamethasone

Beyond the preview

Go deeper on IRCT20160523028008N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160523028008N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call